|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Due from related party- Abpro | ||||||||||||||||||
| Cash and marketable securities held in Trust Account | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Accounts receivable | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Forward purchase agreement asset | ||||||||||||||||||
| Security deposits | ||||||||||||||||||
| SEPA put rights asset | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Cash held in Trust Account | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Right-of-use asset - operating lease | ||||||||||||||||||
| Patents, net | ||||||||||||||||||
| SEPA put rights asset | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and stockholders’ deficit | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Accrued offering costs | ||||||||||||||||||
| Common stock to be redeemed (126,122 and 2,768,301 shares of Series A common stock, respectively) | ||||||||||||||||||
| Series A Common Stock | ||||||||||||||||||
| Total common stock to be redeemed (126,122 and 2,768,301 shares of Series A common stock, respectively) | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Excise taxes payable | ||||||||||||||||||
| Operating lease liability, current | ||||||||||||||||||
| Finance lease liability, current | ||||||||||||||||||
| Income taxes payable | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total income taxes payable | ||||||||||||||||||
| Notes payable, current – related parties | ||||||||||||||||||
| Advance from related parties | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total advance from related parties | ||||||||||||||||||
| Convertible notes | ||||||||||||||||||
| Embedded derivative liability | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||
| Operating lease liability, noncurrent | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Convertible preferred stock, value | ||||||||||||||||||
| Series F Convertible Preferred Stock | ||||||||||||||||||
| Series E Convertible Preferred Stock | ||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||
| Series A Redeemable, Convertible Preferred Stock | ||||||||||||||||||
| Total convertible preferred stock, value | ||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 1,000,000 shares authorized; zero shares issued and outstanding | ||||||||||||||||||
| Common stock, $0.0001 par value; 110,000,000 shares authorized; 5,896,048 and 2,733,263 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Series A Common Stock | ||||||||||||||||||
| Series B Common Stock | ||||||||||||||||||
| Total common stock, $0.0001 par value; 110,000,000 shares authorized; 5,896,048 and 2,733,263 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Treasury stock, 983,333 and 210,166 shares at cost as of December 31, 2024 and 2023, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total Abpro Holdings, Inc.’s stockholders’ deficit | ||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||
| Total liabilities and stockholders’ deficit |
Loading...